TORNTPHARM.NS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 12:59):

Stats
Šios dienos apimtis	146 641
Vidutinė apimtis	256 008
Rinkos kapitalizacija	910.76B
EPS	INR0 ( 2024-02-02 )
Kita pelno data	( INR0 ) 2024-05-28
Last Dividend	INR8.00 ( 2023-06-23 )
Next Dividend	INR0 ( N/A )
P/E	60.90
ATR14	INR2.46 (0.09%)

Tūris Koreliacija

Ilgas: -0.11 (neutral)

Trumpas: 0.21 (neutral)

Signal:(50.488) Neutral

Torrent Pharmaceuticals Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Torrent Pharmaceuticals Koreliacija - Valiuta/Žaliavos

-0.49
( neutral )

-0.38
( neutral )

0.53
( weak )

-0.42
( neutral )

0.33
( neutral )

0.08
( neutral )

Torrent Pharmaceuticals Finansinės ataskaitos

Annual	2022
Pajamos:	INR94.64B
Bruto pelnas:	INR67.29B (71.10 %)
EPS:	INR36.79

FY	2022
Pajamos:	INR94.64B
Bruto pelnas:	INR67.29B (71.10 %)
EPS:	INR36.79

FY	2022
Pajamos:	INR84.19B
Bruto pelnas:	INR58.81B (69.86 %)
EPS:	INR22.97

FY	2021
Pajamos:	INR78.86B
Bruto pelnas:	INR56.51B (71.66 %)
EPS:	INR36.99

Financial Reports:

No articles found.

Torrent Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR14.00 (N/A)	INR8.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Torrent Pharmaceuticals Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.99 - low (32.75%) | Divividend Growth Potential Score: 4.26 - Stable (14.80%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.500	2003-06-10
Last Dividend	INR8.00	2023-06-23
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	32	--
Total Paid Out	INR130.50	--
Avg. Dividend % Per Year	0.85%	--
Score	2.4	--
Div. Sustainability Score	3.99
Div.Growth Potential Score	4.26
Div. Directional Score	4.13	--

Next Divdend (Est)
(2024-09-12)

INR8.12 Estimate 6.85 %

Dividend Stability

0.27 Very Poor

Dividend Score

2.40

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR7.00	1.01%
2019	INR8.50	0.96%
2020	INR7.50	0.81%
2021	INR17.50	1.25%
2022	INR20.00	1.23%
2023	INR22.00	1.42%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TOUCHWOOD.NS	Dividend Junior	2023-09-22	Annually	6	0.15%
PGIL.NS	Dividend Junior	2023-09-01	Annually	17	1.08%
JINDALSAW.NS	Dividend Junior	2023-06-13	Annually	22	1.62%
DEEPAKNTR.NS	Dividend Junior	2023-07-27	Annually	14	0.25%
SKMEGGPROD.NS	Dividend Junior	2023-08-30	Sporadic	21	0.95%
MGEL.NS	Dividend Junior	2023-08-08	Annually	5	0.59%
HARSHA.NS	Dividend Junior	2023-09-20	Insufficient data to determine frequency	2	0.09%
BDL.NS	Dividend Junior	2023-09-20	Semi-Annually	7	1.17%
PTC.NS	Dividend Knight	2023-09-20	Annually	21	6.06%
KDDL.NS	Dividend Junior	2023-09-22	Annually	8	0.29%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.146	1.500	7.09	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.233	1.500	8.52	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	6.33	1.000	8.77	8.77	[3 - 30]
operatingCashFlowPerShareTTM	47.33	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	47.33	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.737	1.000	1.045	1.045	[0.2 - 0.8]
operatingProfitMarginTTM	0.234	1.000	7.32	7.32	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.99

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	60.59	1.000	3.98	0	[1 - 100]
returnOnEquityTTM	0.233	2.50	9.05	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	47.33	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	1.115	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	47.33	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-1.597	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.155	1.000	8.62	0	[0.1 - 0.5]
Total Score				4.26

Torrent Pharmaceuticals

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. It offers products in various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, women healthcare, diabetology, pain management, gynecology, oncology, and anti-infective, as well as provides vitamins, minerals, and nutrients. The company also provides contract manufacturing services. It has licensing collaborations of Baricitinib, Molnupiravir, and Paxlovid for its Covid portfolio. Torrent Pharmaceuticals Limited was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.